|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192976-02
|
$144,556
|
$76,615
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
|
Age and Diet: Major interacting factors that drive sporadic intestinal cancer
|
5R01CA174432-02
|
|
$0
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Age and Diet: Major interacting factors that drive sporadic intestinal cancer
|
6R01CA174432-03
|
$660,173
|
$660,173
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
DNA Mismatch repair and cancer in murine models
|
5R01CA076329-18
|
$294,353
|
$294,353
|
EDELMANN, WINFRIED
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
DNA Mismatch repair and cancer in murine models
|
6R01CA076329-19
|
$86,232
|
$86,232
|
EDELMANN, WINFRIED
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Core Support for Cancer Center
|
3P30CA013330-43S1
|
$199,871
|
$17,988
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Core Support for Cancer Center
|
5P30CA013330-42
|
|
$0
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Core Support for Cancer Center
|
6P30CA013330-43
|
$3,696,138
|
$332,652
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Development of Novel Drugs to Alleviate CPT-11 Toxicity
|
5R01CA161879-04
|
$326,465
|
$326,465
|
MANI, SRIDHAR
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Development of Novel Drugs to Alleviate CPT-11 Toxicity
|
6R01CA161879-05
|
$1
|
$1
|
MANI, SRIDHAR
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
The B7x pathway in the tumor microenvironment
|
5R01CA175495-02
|
$28,106
|
$7,027
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
The B7x pathway in the tumor microenvironment
|
6R01CA175495-03
|
$318,419
|
$79,605
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
The Impact of a Targeted CRC Screening Intervention among Latinos in Central PA
|
5K01CA151752-05
|
$137,943
|
$137,943
|
DOMINIC, ORALIA
|
ALLEGHENY-SINGER RESEARCH INSTITUTE
|
|
|
Global Proteomic Screening by MALDI Spectrometric Imaging of Protein-Bead Arrays
|
5R44CA161965-04
|
$499,744
|
$499,744
|
LIM, MARK
|
AMBERGEN, INC
|
|
|
(PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal Cancer
|
5R01CA184820-02
|
$399,582
|
$399,582
|
DUBOIS, RAYMOND
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Exploiting the immune response to detect pathogen-induced cancers
|
1R01CA199948-01
|
$517,230
|
$517,230
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Navigation from Community to Clinic to promote CRC Screening in Underserved Popul
|
5R01CA162393-04
|
$560,038
|
$560,038
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-09
|
$3,155,163
|
$94,655
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S2
|
$112,151
|
$3,365
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-09S3
|
$183,048
|
$5,491
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Gut L-Histidine Metabolism and Histamine Signaling in Colonic Neoplasia
|
5U01CA170930-03
|
$584,586
|
$584,586
|
VERSALOVIC, JAMES
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Development of microRNA Biomarkers For Noninvasive Detection of Colorectal Cancer
|
1R01CA184792-01A1
|
$360,402
|
$360,402
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
|
Familial and Early Onset Colorectal Cancer
|
2R01CA072851-19
|
$372,400
|
$372,400
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
|
METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER
|
5R01CA181572-02
|
$320,751
|
$320,751
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
|
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data
|
5U01CA187956-02
|
$571,122
|
$571,122
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
|
CpG-ODN Coated Hollow Gold Nanoshells for Photothermal Therapy
|
5R01CA172836-03
|
$342,894
|
$171,447
|
FOSTER, AARON
|
BELLICUM PHARMACEUTICALS, INC.
|
|
|
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
|
1U01CA199252-01
|
$1,080,326
|
$540,163
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Basic and Translational studies of Ras-mutant colorectal cancer
|
5R01CA178017-02
|
$359,556
|
$359,556
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Controlling cancer with aspirin-triggered stimulation of resolution
|
5R01CA170549-04
|
$506,329
|
$172,152
|
PANIGRAHY, DIPAK
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Targeting orphan nuclear receptor TR3/Nur77 for tumor angiogenesis
|
1R03CA191463-01A1
|
$87,000
|
$87,000
|
ZENG, HUIYAN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Role of c-Cbl in Colon cancer
|
5R01CA175382-02
|
$361,050
|
$361,050
|
CHITALIA, VIPUL
|
BOSTON MEDICAL CENTER
|
|
|
Spectral Markers for Early Detection of Colon Neoplasia
|
3U01CA111257-10S1
|
$190,284
|
$190,284
|
ROY, HEMANT
|
BOSTON MEDICAL CENTER
|
|
|
Transforming Colorectal Cancer Screening through Multimodal Spectral Markers
|
5R01CA156186-06
|
$522,033
|
$522,033
|
ROY, HEMANT
|
BOSTON MEDICAL CENTER
|
|
|
Towards Development of an in vitro Assay to Personalize Colonic Chemoprevention
|
1R03CA195143-01
|
$87,000
|
$87,000
|
WALI, RAMESH
|
BOSTON MEDICAL CENTER
|
|
|
High resolution phase contrast endoscopy
|
5R01CA182939-02
|
$345,234
|
$345,234
|
MERTZ, JEROME
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
5R01CA181392-02
|
$675,649
|
$675,649
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
IGPR-1 in colon cancer chemotherapy
|
1R21CA193958-01
|
$213,629
|
$213,629
|
RAHIMI, NADER
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-04
|
$3,334,936
|
$666,987
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-29S2
|
$334,740
|
$76,990
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S1
|
$34,176
|
$1,709
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-02S2
|
$810,357
|
$40,518
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-02
|
$9,967,453
|
$498,373
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
The VITamin D and OmegA-3 TriaL (VITAL)
|
2R01CA138962-07
|
$3,124,816
|
$1,062,437
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
2P01CA087969-16
|
$2,457,338
|
$909,215
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Calcium and Colorectal Cancer: Gene-Environment Interactions and Molecular Pathwa
|
1K07CA188126-01A1
|
$144,000
|
$144,000
|
ZHANG, XUEHONG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Calcium Intake and Colorectal Cancer Incidence and Survival
|
5R03CA176717-02
|
$88,667
|
$88,667
|
ZHANG, XUEHONG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Systematic identification of oncogenic KRAS synthetic lethal interactions
|
1U01CA199253-01
|
$817,805
|
$278,054
|
HAHN, WILLIAM
|
BROAD INSTITUTE, INC.
|
|
|
Genome Characterization Center (GCC)
|
3U24CA143867-05S2
|
$364,797
|
$120,383
|
MEYERSON, MATTHEW
|
BROAD INSTITUTE, INC.
|
|
|
Neighborhood obesogenic environment in relation to obesity-related biomarkers in
|
3R01CA154644-05S1
|
$38,297
|
$12,638
|
CHENG, IONA
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
|
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer
|
4R44CA176937-02
|
$903,055
|
$903,055
|
LING, XIANG
|
CANGET BIOTEKPHARMA, LLC
|
|
Total relevant funding to Colon/Rectum for this search: $209,309,046
|
